Molecule News and Research

RSS

Breakthrough Alzheimer's discovery

A new study has found that the neurons in the brain can alter their genetic make-up unlike other cells of the body which remain constant.

22 Nov 2018

UH pharmaceutical scientist developing new drug to treat children with rare genetic disorder

A University of Houston pharmaceutical scientist is developing a new drug which could bring relief to children suffering with Familial Adenomatous Polyposis, a rare genetic disorder characterized by hundreds - if not thousands - of colorectal polyps.

21 Nov 2018

'Unknown' enzyme may be key to new treatment for inflammatory diseases

An enzyme that normally repairs damaged DNA, may be the key to a new treatment for inflammatory diseases.

20 Nov 2018

DNA vaccine reduces levels of toxic proteins in Alzheimer’s model

Researchers have developed a new DNA vaccine that reduces the build-up of the toxic proteins associated with Alzheimer’s disease.

20 Nov 2018

Scientists use cryo-EM to capture freeze-frames of molecule’s 'lock-and-load' on DNA

Pushing the limits of cryo-electron microscopy, University of California, Berkeley, scientists have captured freeze-frames of the changing shape of a huge molecule, one of the body's key molecular machines, as it locks onto DNA and loads the machinery for reading the genetic code.

20 Nov 2018

Study warns that potential epigenetic therapy may boost lung cancer stem cells

Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

20 Nov 2018

Towards finding a druggable cancer target

It's known that cancer involves unchecked cell growth and that a biological pathway that regulates organ size, known at the Hippo pathway, is also involved in cancer.

19 Nov 2018

New glucose binding molecule could be key to better metabolic control for diabetics

Scientists from the University of Bristol have designed a new synthetic glucose binding molecule platform that brings us one step closer to the development of the world's first glucose-responsive insulin which, say researchers, will transform the treatment of diabetes.

19 Nov 2018

2PG Company receives grant to develop sensitive, low-cost molecular diagnostic tests for tuberculosis

Two Pore Guys, Inc. today announced that the company has received a $2.8 million grant from the Bill & Melinda Gates Foundation to develop sensitive, low-cost molecular diagnostic tests for tuberculosis using its solid-state nanopore technology.

19 Nov 2018

Researchers identify molecule to fight myotubular myopathy

Myotubular myopathy is a severe genetic disease that leads to muscle paralysis from birth and results in death before two years of age. Although no treatment currently exists, researchers from the University of Geneva, Switzerland, - working in collaboration with the University of Strasbourg, France, - have identified a molecule that not only greatly reduces the progression of the disease but also boosts life expectancy in animal models by a factor of seven.

19 Nov 2018

Scientists equip new virus that kills carcinoma cells with protein

Scientists have equipped a virus that kills carcinoma cells with a protein so it can also target and kill adjacent cells that are tricked into shielding the cancer from the immune system.

19 Nov 2018

Surprising discovery about BH4 may rekindle interest in once-promising pathway

In 2013, renowned Boston Children's Hospital pain researcher Clifford Woolf, MB, BCh, PhD, and chemist Kai Johnsson, PhD, his fellow co-founder at Quartet Medicine, believed they held the key to non-narcotic pain relief.

19 Nov 2018

Scientists discover new inhibitor that decreases lung inflammation

Scientists from the University of Sheffield have discovered a new inhibitor which decreases lung inflammation and could hold the key to treating Acute Respiratory Distress Syndrome - a life-threatening disease which affects thousands of people in the UK.

18 Nov 2018

New method to analyze cell membrane complexes could revolutionize the way we study diseases

Researchers have developed a new technique to analyze cell membrane proteins in situ which could revolutionize the way in which we study diseases, such as cancer, metabolic and heart diseases.

17 Nov 2018

Lab Innovations 2018 has beaten all records by attracting 3,113 attendees

Lab Innovations, the UK’s only trade show dedicated to the laboratory industry, beat all records for the show, attracting 3,113 attendees - a 10% increase on the previous year. Underlying the headline number were significant increases in visitors involved in purchasing products and services.

From Lab Innovations 16 Nov 2018

Researchers develop new drug molecule that inhibits inflammation

A multidisciplinary team of researchers led from Karolinska Institutet in Sweden have developed an anti-inflammatory drug molecule with a new mechanism of action.

15 Nov 2018

Scientists try to develop portable systems that can quickly produce biologics on demand

Many life-saving medicines, including insulin, antibodies and vaccines, are derived from living cells. These "biologics" can be difficult to obtain and store on the battlefield or in remote areas.

15 Nov 2018

Inhibition of one protein clears toxic clumps seen in Parkinson's disease, study finds

A defining feature of Parkinson's disease is the clumps of alpha-synuclein protein that accumulate in the brain's motor control area, destroying dopamine-producing neurons.

14 Nov 2018

Speed and error rate of DNA synthesis influenced by DNA structure

The speed and error rate of DNA synthesis is influenced by the three-dimensional structure of the DNA. Using "third-generation" genome-wide DNA sequencing data, a team of researchers from Penn State and the Czech Academy of Sciences showed that sequences with the potential to form unusual DNA conformations, which are frequently associated with cancer and neurological diseases, can in fact slow down or speed up the DNA synthesis process and cause more or fewer sequencing errors.

14 Nov 2018

Enable Injections enters into development agreements with UCB and Apellis Pharmaceuticals

Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.

14 Nov 2018

Molecule News and Research

Breakthrough Alzheimer's discovery

UH pharmaceutical scientist developing new drug to treat children with rare genetic disorder

'Unknown' enzyme may be key to new treatment for inflammatory diseases

DNA vaccine reduces levels of toxic proteins in Alzheimer’s model

Scientists use cryo-EM to capture freeze-frames of molecule’s 'lock-and-load' on DNA

Study warns that potential epigenetic therapy may boost lung cancer stem cells

Towards finding a druggable cancer target

New glucose binding molecule could be key to better metabolic control for diabetics

2PG Company receives grant to develop sensitive, low-cost molecular diagnostic tests for tuberculosis

Researchers identify molecule to fight myotubular myopathy

Scientists equip new virus that kills carcinoma cells with protein

Surprising discovery about BH4 may rekindle interest in once-promising pathway

Scientists discover new inhibitor that decreases lung inflammation

New method to analyze cell membrane complexes could revolutionize the way we study diseases

Lab Innovations 2018 has beaten all records by attracting 3,113 attendees

Researchers develop new drug molecule that inhibits inflammation

Scientists try to develop portable systems that can quickly produce biologics on demand

Inhibition of one protein clears toxic clumps seen in Parkinson's disease, study finds

Speed and error rate of DNA synthesis influenced by DNA structure

Enable Injections enters into development agreements with UCB and Apellis Pharmaceuticals

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News